logo
logo

New long-acting approach for malaria therapy developed

avatar
David Carter
img

Every year, malaria afflicts hundreds of millions of people and kills hundreds of thousands of children.

Currently, the best available prevention of malaria requires oral dosing of antimalarial tablets.

The study, led by Pharmacologist Professor Andrew Owen and Materials Chemist Professor Steve Rannard, aimed to utilise nanotechnology to improve the delivery of an existing antimalarial drug via a novel injectable format that can maintain blood concentration of the drug for weeks or months following a single dose.

Nanotechnology is the manipulation of matter on an atomic, molecular, and supramolecular scale.

Nanomedicine is the application of nanotechnology to the diagnosis, prevention or treatment of disease in the human body.

These particles have an approximate diameter that is 1/500th the width of a human hair, and once injected into the muscle, establish a drug depot that releases drug into the bloodstream over an extended period of time.

collect
0
avatar
David Carter
guide
Zupyak is a free content platform for publishing and discovering stories, software and startups.